Canntab Therapeutics Limited announces private placement16,666,666 Common Shares at a issue price of CAD 0.006 per Common Share for gross proceeds of CAD 99,999.996 on April 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142K | |
+37.08% | 5.92B | |
-17.43% | 4.51B | |
-9.46% | 3.15B | |
+0.51% | 3.1B | |
-3.53% | 2.42B | |
+41.15% | 1.97B | |
-5.15% | 1.68B | |
+0.09% | 1.65B | |
-10.38% | 1.53B |
- Stock Market
- Equities
- PILL Stock
- News Canntab Therapeutics Limited
- Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding